Sarah Fenton

Oct 15, 2024 | thedmonline.com | Sarah Fenton

Reading Time: 2 mins read This season has been unpredictable for Ole Miss Football. While the Rebels entered as a confident playoff contender, they have fallen in games that are crucial to their playoff path. The team started off strong by dominating unranked non-conference teams and has now lost two out of three games during SEC play. Out of the Rebels’ two losses to LSU and Kentucky, Ole Miss was favored to win them both.

Aug 20, 2024 | tandfonline.com | Sarah Fenton

References Robinson D, Van Allen EM, Wu YM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(open in a new window)(5(open in a new window)):1215–1228. doi: 10.1016/j.cell.2015.05.001  (Open in a new window)PubMed (Open in a new window)Web of Science ®(Open in a new window)Google Scholar Leongamornlert D, Mahmud N, Tymrakiewicz M, et al. Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer. 2012;106(open in a new window)(10(open in a new window)):1697–1701.

Apr 8, 2024 | cancernetwork.com | Maha Hussain |Sarah Fenton

As part of Breaking Barriers: Women in Oncology, Maha H. Hussain, MD, and Sarah E. Fenton, MD, PhD, spoke with CancerNetwork® about developments in their careers and the evolution of research in the genitourinary oncology (GU) field. Additionally, they discussed their personal experiences in the field, which ranged from applying key pieces of advice from former mentors, handling challenges, and maintaining a healthy work/life balance. Hussain is a Genevieve E.

Apr 3, 2024 | cancernetwork.com | Maha Hussain |Sarah Fenton

Work-life balance can be especially difficult for female physicians in genitourinary (GU) oncology, given the demanding nature of the field. In a recent conversation with CancerNetwork® in Breaking Barriers: Women in Oncology, Maha H. Hussain, MD, and Sarah E. Fenton, MD, PhD, focused on how they decided to start families and if it impacted their work. Hussain, a Genevieve E.

Apr 2, 2024 | cancernetwork.com | Maha Hussain |Sarah Fenton

When Maha H. Hussain, MD, was beginning her career in the genitourinary [GU] oncology field, resources were limited in terms of funding. Since then, this field has evolved with government and pharmaceutical companies investing in these research practices. In a recent conversation with CancerNetwork® for Breaking Barriers: Women in Oncology, Hussain, a Genevieve E.